Assessment of mean platelet volume (MPV) in primary hyperparathyroidism: Effects of successful parathyroidectomy on MPV levels

Endocrine Regulations

Volumn 48, Issue 4, 2014, Pages 182-188

  Yilmaz, Hakki ^a,b  

^a TURGUT OZAL UNIVERSITY   (Turkey)

^b Diskapi Yildirim Beyazid Education and Research Hospital   (Turkey)

Author keywords

Cured parathyroidectomy; MPV; Primary hyperparathyroidism; PTH

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CREATININE; PARATHYROID HORMONE;

ADULT; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; DIABETES MELLITUS; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEPHROLITHIASIS; OSTEOPOROSIS; PARATHYROID ADENOMA; PARATHYROIDECTOMY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIMARY HYPERPARATHYROIDISM; RETROSPECTIVE STUDY; SCORING SYSTEM; THROMBOCYTE ACTIVATION; THROMBOCYTE VOLUME; VITAMIN D DEFICIENCY; AGED; BLOOD; HYPERPARATHYROIDISM, PRIMARY; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CALCIUM; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MEAN PLATELET VOLUME; MIDDLE AGED; PARATHYROID HORMONE; PARATHYROIDECTOMY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84928636454     PISSN: 12100668     EISSN: 13360329     Source Type: Journal    
DOI: 10.4149/endo_2014_04_182     Document Type: Article

References (32)

1. Andersson P, Rydberg E, Willenheimer R: Primary hyperparathyroidism and heart disease: a review. Eur Heart J 25, 1776-1787, 2004. http://dx.doi.org/10.1016/j.ehj.2004.07.010
2. Bath PM, Butterworth RJ: Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 7, 157-161, 1996. http://dx.doi.org/10.1097/00001721-199603000-00011
3. Battinelli E, Willoughby SR, Foxall T, Valeri CR, Loscalzo J: Induction of platelet formation from megakaryocytoid cells by nitric oxide. Proc Natl Acad Sci USA 98, 14458-14463, 2001. http://dx.doi.org/10.1073/pnas.241427398
4. Bilezikian JP, Khan AA, Potts JT Jr; Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism: Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 94, 335-339, 2009. http://dx.doi.org/10.1210/jc.2008-1763
5. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15, 2208-2218, 2004. http://dx.doi.org/10.1097/01.ASN.0000133041.27682.A2
6. Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, Mohler ER, Reilly MP, Berger JS: Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 8, 148-156, 2010. http://dx.doi.org/10.1111/j.1538-7836.2009.03584.x
7. Coppinger JA, Cagney G, Toomey S, Kislinger T, Belton O, McRedmond JP, Cahill DJ, Emili A, Fitzgerald DJ, Maguire PB: Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 103, 2096-2104, 2004. http://dx.doi.org/10.1182/blood-2003-08-2804
8. Davi G, Patrono C: Platelet activation and atherothrombosis. N Engl J Med357, 2482-2494, 2007. http://dx.doi.org/10.1056/NEJMra071014
9. Emam AA, Mousa SG, Ahmed KY, Al-Azab AA: Inflammatory biomarkers in patients with asymptomatic primary hyperparathyroidism. Med Princ Pract 21, 249-253, 2012. http://dx.doi.org/10.1159/000334588
10. Fliser D, Franek E, Fode P, Stefanski A, Schmitt CP, Lyons M, Ritz E: Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humans. Nephrol Dial Transplant 12, 933-938, 1997. http://dx.doi.org/10.1093/ndt/12.5.933
11. Garcia de la Torre N, Wass JA, Turner HE: Parathyroid adenomas and cardiovascular risk. Endocr Relat Cancer 10, 309-322,2003. http://dx.doi.org/10.1677/erc.0.0100309
12. Hagstrom E, Hellman P, Lundgren E, Lind L, Arnlov J: Serum calcium is independently associated with insulin sensitivity measured with euglycaemic-hyperinsulinaemic clamp in a community based cohort. Diabetologia 50, 317-324, 2007. http://dx.doi.org/10.1007/s00125-006-0532-9
13. Hagstrom E, Hellman P, Larsson TE, Ingelsson E, Berglund L, Sundstrom J, Melhus H, Held C, Lind L, Michaelsson K, Arnlov J: Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 119, 2765-2771, 2009. http://dx.doi.org/10.1161/CIRCULATIONAHA.108.808733
14. Hedback G, Tisell LE, Bengtsson BA, Hedman I, Oden A: Premature death in patients operated on for primary hyperparathyroidism. World J Surg 14, 829-836, 1990. http://dx.doi.org/10.1007/BF01670531
15. Hedback G, Oden A: Increased risk of death from primary hyperparathyroidism - an update. Eur J Clin Invest 28, 277-278, 1998.
16. Jung DH, Lee HR, Lee YJ, Kim JK, Park BJ, Shim JY: The association between coronary artery calcification and mean platelet volume in the general population. Platelets 22, 567-571, 2011. http://dx.doi.org/10.3109/09537104.2011.580397
17. Klovaite J, Benn M, Yazdanyar S, Nordestgaard BG: High platelet volume and increased risk of myocardial infarction: 39,531 participants from the general population. J Thromb Haemost 9, 49-56, 2011. http://dx.doi.org/10.1111/j.1538-7836.2010.04110.x
18. Leifsson BG, Ahren B: Serum calcium and survival in a large health screening program. J Clin Endocrinol Metab 81, 2149-2153, 1996.
19. Lind L, Skarfors E, Berglund L, Lithell H, Ljunghall S: Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. J Clin Epidemiol 50, 967-973, 1997. http://dx.doi.org/10.1016/S0895-4356(97)00104-2
20. Lundgren E, Lind L, Palmer M, Jakobsson S, Ljunghall S, Rastad J: Increased cardiovascular mortality and normalized serum calcium in patients with mild hypercalcemia followed up for 25 years. Surgery 130, 978-985, 2001. http://dx.doi.org/10.1067/msy.2001.118377
21. Marx SJ: Hyperparathyroid and hypoparathyroid disorders. N Engl J Med 343, 1863-1875, 2000. http://dx.doi.org/10.1056/NEJM200012213432508
22. Meadows TA, Bhatt DL: Clinical aspects of platelet inhibitors and thrombus formation. Circ Res 100, 1261-1275, 2007. http://dx.doi.org/10.1161/01.RES.0000264509.36234.51
23. Nilsson IL, Aberg J, Rastad J, Lind L: Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy. Surgery 126, 1049-1055, 1999. http://dx.doi.org/10.1067/msy.2099.101422
24. Ogard CG, Engholm G, Almdal TP, Vestergaard H: Increased mortality in patients hospitalized with primary hyperparathyroidism during the period 1977-1993 in Denmark. World J Surg 28, 108-111, 2004. http://dx.doi.org/10.1007/s00268-003-7046-0
25. Rashid G, Bernheim J, Green J, Benchetrit S: Parathyroid hormone stimulates the endothelial nitric oxide synthase through protein kinase A and C pathways. Nephrol Dial Transplant 22, 2831-2837, 2007. http://dx.doi.org/10.1093/ndt/gfm269
26. Robinson SD, Harding SA, Cummins P, Din JN, Sarma J, Davidson I, Fox KA, Boon NA, Newby DE: Functional interplay between platelet activation and endothelial dysfunction in patients with coronary heart disease. Platelets 17, 158-162, 2006. http://dx.doi.org/10.1080/17476930500454514
27. Salzman EW, Ware JA: Ionized calcium as an intracellular messenger in blood platelets. Hemost Thromb 7, 177-202, 1984.
28. Solomon BL, Schaf M, Smallridge RC: Psychological symptoms before and after parathyroid surgery. Am J Med 96, 101-106, 1994. http://dx.doi.org/10.1016/0002-9343(94)90128-7
29. Tassone F, Procopio M, Gianotti L, Visconti G, Pia A, Terzolo M, Borretta G: Insulin resistance is not coupled with defective insulin secretion in primary hyperparathyroidism. Diabet Med 26, 968-973, 2009. http://dx.doi.org/10.1111/j.1464-5491.2009.02804.x
30. Vestergaard P, Mollerup CL, Frokjaer VG, Christiansen P, Blichert-Toft M, Mosekilde L: Cardiovascular events before and after surgery for primary hyperparathyroidism. World J Surg 27, 216-222, 2003.
31. Wermers RA, Khosla S, Atkinson EJ, Grant CS, Hodgson SF, O'Fallon WM, Melton LJ 3rd: Survival after the diagnosis of hyperparathyroidism: a population-based study. Am J Med 2, 115-122, 1998. http://dx.doi.org/10.1016/S0002-9343(97)00270-2
32. Yu N, Donnan PT, Leese GP: A record linkage study of outcomes in patients with mild primary hyperparathyroidism: The Parathyroid Epidemiology and Audit Research Study (PEARS). Clin Endocrinol (Oxf) 75, 169-176, 2011. http://dx.doi.org/10.1111/j.1365-2265.2010.03958.x